Clinical Trial Tests New Combinations of Immunotherapy Drugs to Treat Osteosarcoma
Friday, May 6th, 2022
Medications bring months more of life to dog Jelly Bean

Friday, May 6th, 2022
Medications bring months more of life to dog Jelly Bean
Tuesday, April 26th, 2022
Stalwart Chesapeake Bay Retriever thrives after second cancer diagnosis
Monday, March 7th, 2022
Heart damage has emerged among the distressing side effects of certain chemotherapy drugs
Tuesday, February 15th, 2022
Dr. Mahoney brings deep expertise in oncology to the classroom, clinics, research, and her patients at Foster Hospital
Tuesday, December 7th, 2021
Dr. Gardner studies bone cancer in dogs to develop new treatment options
Tuesday, May 11th, 2021
Professor Cheryl London spoke with AKC Family Dog about the benefits of companion animal clinical trials, including a current lymphoma trial at Foster Hospital
Monday, February 15th, 2021
Research assistant professor Vicky Yang talks to WCVB Boston about work with Tufts Medical Center to study cancer treatment side effects in dogs and people
Monday, December 14th, 2020
Tufts’ human and veterinary medical researchers collaborate to prevent and better treat cardiovascular damage in people and pets who have survived cancer
Monday, October 26th, 2020
A clinical trial looks at whether combining immunotherapy with low doses of chemotherapy can improve outcomes and quality of life for dogs—and someday people.
Wednesday, February 19th, 2020
Cummings School’s Cheryl London is featured prominently in this Boston 25 News story on why golden retrievers are more susceptible to developing cancers than other dog breeds.